Results 231 to 240 of about 50,723 (266)

BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients

Cancers, 2022
Ji Hoon Park, Jung Hyun Jo, Sung Ill Jang   +2 more
exaly  

BRCA 1, BRCA 2 models.

Journal of insurance medicine (New York, N.Y.), 1997
M L, Engman, C A, Pinkham
openaire   +1 more source

BRCA inequality

Nature Reviews Cancer, 2011
openaire   +1 more source

Racial Differences in BRCA Testing

JAMA: The Journal of the American Medical Association, 2005
Sharon Hensley, Alford, Judy, Mouchawar
openaire   +2 more sources

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

Ca-A Cancer Journal for Clinicians, 2017
Paul J Hoskins, Walter H Gotlieb
exaly  

The spectrum of BRCA mutations and characteristics of BRCA‐associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next‐generation sequencing

International Journal of Cancer, 2017
Xin Hu, Chuan-Gui Song, Zhi-Gang Zhuang   +2 more
exaly  

Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity

Annals of Oncology, 2011
D J Gallagher, J Bhatia, P Sabbatini
exaly  

BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling

Cancer Treatment Reviews, 2001
M O Nicoletto, Arcangela De Nicolò, Giuseppe Luigi Banna   +2 more
exaly  

BRCA

2006
openaire   +1 more source

[Review of the literature on BRCA 1 and BRCA 2].

Minerva ginecologica, 2002
R, Saponara, A, Menditto, G, Russo, R, Musone, G C, Balbi, C, Balbi   +5 more
openaire   +1 more source